# Rifapentine

## Priftin 150mg (Government)

#### 一般可用

| 藥品代碼       | ORPT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:---------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Inactive tuberculosis， With isoniazid in patients with high risk of progression to active disease Tuberculosis，                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 用法用量       | Adult: in combination with isoniazid 15 mg/kg (rounded up to the nearest 50 or 100 mg; MAX， 900 mg) 25.1-32 kg once a week， Rifapentine 600 mg each time; 32.1-50 kg once a week， Rifapentine 750 mg each time; >50 kg once a week， Rifapentine 900 mg each time (maximum Dose: 900 mg) for 12 weeks. Children: in combination with isoniazid 15 mg/kg (rounded up to the nearest 50 or 100 mg; MAX， 900 mg); 10-14 kg once a week， Rifapentine 300 mg each time; 14.1-25 kg once a week， Rifapentine 450 mg each time; 25.1-32 kg once a week， Rifapentine 600 mg each time; 32.1-50 kg once a week， Rifapentine 750 mg each time; >50 kg once a week， Rifapentine 900 mg each time (maximum dose: 900 mg) for 12 weeks. |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 禁忌           | Hypersensitivity to rifamycins. concomitant use with rilpivirine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 副作用         | Common Dermatologic: Rash (2.5% to 4.2% ) Gastrointestinal: Clostridium difficile diarrhea Hematologic: Anemia (1.6% to 11.4% ) Hepatic: ALT/SGPT level raised (2.2% to 5% )， AST/SGOT level raised (2.2% to 4.2% ) Immunologic: Lymphocytopenia (3.2% to 10.5% ) Musculoskeletal: Arthralgia (0.9% to 3.6% ) Neurologic: Headache (0.9% to 3% ) Ophthalmic: Conjunctivitis (0.3% to 2.2% ) Respiratory: Hemoptysis (1.9% to 7.5% ) Other: Abnormal color， Red/orange body fluid Serious Hematologic: Neutropenia (6.1% to 8.5% ) Hepatic: Hepatotoxicity Immunologic: Hypersensitivity reaction (Adult， 4%; pediatric， 1.3% )                                                                                                  |
| 孕期用藥建議   | No (limited) human data – animal data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

